Foundation

At the 14th Conference of the International Mesothelioma Interest Group (iMig) in Ottawa, Canada, this May, mesothelioma research was presented in a number of plenary sessions and dozens of mini-symposiums. The topics of the sessions ranged from mesothelioma immunotherapy and surgery to imaging and biomarkers. Many advances in the study and diagnosis of the pleural mesothelioma tumor were presented to the gathering of mesothelioma researchers. During these topical sessions, dozens of scientific studies were presented, showing the vibrant state of mesothelioma science. Kazan Law, which … [Read more...]

Starting on May 2, 2018, a remarkable group of people will gather in Ottawa, Canada: the International Mesothelioma Interest Group. The group is made up of medical researchers, oncologist, doctors, and advocates bound together by their interest in advancing knowledge about mesothelioma tumors and mesothelioma treatment. Steven Kazan, Founding, Senior and Managing Partner of Kazan Law, which sponsors the Mesothelioma Circle blog to share information with mesothelioma patients and their families, is also one of the sponsors of the biannual meeting of the International Mesothelioma Interest … [Read more...]

Breakthroughs in mesothelioma treatment are happening with record speed and frequency. One of the United States’ top medical schools wants to move medical research forward even faster. The University of California San Francisco (UCSF) has launched an ambitious fundraising campaign to spur innovation in medicine across a range of disciplines and diseases. One of the beneficiaries of this fundraising is likely to be robotic mesothelioma surgery. Steven Kazan, founding partner at Kazan Law, attended laboratory tours during a recent event for the UCSF fundraising campaign. The Kazan McClain … [Read more...]

The most exciting developments in mesothelioma treatment right now are immunotherapy drugs such as nivolumab (also known by its brand name Opdivo) and ipilimumab (also sold as Yervoy). A mesothelioma clinical trial underway now will study the effectiveness of a combination of nivolumab and Ipilimumab as first line treatments for non-operable pleural mesothelioma. The trial is taking place in 127 cities around the world, including 17 locations in the United States. It is a Phase III clinical trial of the combination nivolumab and ipilimumab protocol. This means that at least two earlier … [Read more...]

A mesothelioma diagnosis is never good news. But one family in Northern California turned their misfortune into a way to help other mesothelioma patients find better treatments. With the settlement money Kazan Law negotiated on their behalf, they created the Boyd Family Fund at Kazan McClain Partners’ Foundation to fund clinical trials research. One trial of a mesothelioma immunotherapy treatment, partially supported by the Boyd Family Fund, is showing promising early results. The Boyds’ commitment to finding better mesothelioma immunotherapy treatments shows how mesothelioma patients and … [Read more...]

Over the years our sponsor, Kazan Law, has built philanthropic relationships with mesothelioma clients to help fund mesothelioma research and new mesothelioma technology. One such example is mesothelioma victim Gordon Bankhead and his wife, Emily, who wanted to give back and do more for future generations of asbestos victims. As a result of Kazan Law’s supportive relationship with UCSF’s Thoracic Oncology Program, the Bankhead family generously donated $100,000 from their jury verdict award towards the purchase of a $750,000 machine that utilizes innovative new technology for mesothelioma … [Read more...]

Our mesothelioma law firm’s charitable foundation, the Kazan McClain Partners’ Foundation, has partnered with and donated more than $20 million in grant monies to community, health, and civic organizations. One of our foundation’s most collaborative partners is the University of California, San Francisco (UCSF), a world renowned cancer research institution and the top public recipient of National Institutes of Health (NIH) research funding for the 6th consecutive year in 2017. In 2014, our foundation provided a large donation to UCSF cancer researchers seeking to understand mesothelioma cancer … [Read more...]

Mesothelioma Circle’s sponsor, Kazan, McClain, Satterley & Greenwood, has been a pioneering force in asbestos litigation since 1974. The firm’s charitable foundation, the Kazan McClain Partners’ Foundation, formed in 1994, has pledged their serious and substantial commitment to giving back by donating more than $20 million in grant monies to community, health, and civic organizations. A sizable portion of this commitment has gone to funding mesothelioma research in the hopes of accelerating the process of finding new breakthroughs in the fight against this life-threatening disease. Keeping … [Read more...]